Blue Faery Gives Annual Liver Cancer Research Award
Dr. Xin W. Wang, Senior Investigator at the National Cancer Institute, wins Blue Faery Award twice
News provided by
Share this article
Share this article
LOS ANGELES, April 8, 2021 /PRNewswire/ Blue Faery: The Adrienne Wilson Liver Cancer Association is proud to announce the annual Blue Faery Award (BFA) for Excellence in Liver Cancer Research. Primary liver cancer, also known as Hepatocellular Carcinoma (HCC), is the third leading cause of cancer deaths worldwide. Blue Faery created the award to recognize medical professionals who develop innovative research in HCC.
Upon receiving the BFA Dr. Wang stated, I am so thrilled to hear this wonderful news. It s an absolute honor to receive this year s award, especially in the midst of the COVID-19 pandemic and as the recipient who has ever won this award twice. Thanks to the board for recognizing our works.
It s Love Your Liver month: Are you looking after yours? droitwichstandard.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from droitwichstandard.co.uk Daily Mail and Mail on Sunday newspapers.
Covid pandemic could lead to tens of thousands more liver disease cases in 2021, warns charity
THE British Liver Trust is calling for every person in the UK to consider their liver health and take a simple quiz to assess their risk during January after adults across the UK admit to making unhealthy lifestyle choices in 2020.
Over a million adults in the UK may currently have the early stages of liver disease but are unaware and have no symptoms.1,3. Worryingly, rising rates of obesity means that 150,000 children could also have non-alcohol related fatty liver disease.2
January is often a time that people take stock after the Christmas period but this year it is even more important as the numbers at risk have also increased during the Covid pandemic. Many people have increased their alcohol consumption and gained weight during lockdown – the two biggest risk factors for developing liver disease.